Trial intelligence / Profile preview

Taxotere vs Pemetrexed in 1st Line Non-squamous NSCLC

NCT01282151Phase 3Terminated

Sponsor
Chonnam National University Hospital
Start
Jul 2011
Primary completion
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by Chonnam National University Hospital. Started Jul 2011; status: terminated.

02

Drugs

docetaxel
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT01282151.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01282151.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call